| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Infectious Diseases | 191 / 361 | 47th | Q3 |
| Immunology | 170 / 243 | 30th | Q3 |
Compare journals
Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Vacunas
Vacunas is Scopus-indexed (Q3, CiteScore 3.1). Published by Ediciones Doyma, S.L..
Checked against the index lists dated .
ISSN 1576-9887Verify ISSN ↗1578-8857Verify ISSN ↗
Publisher: Ediciones Doyma, S.L.
Cost to publish: About US$2,960 to publish open access (publisher list price, via OpenAlex) — subscription publishing may be free
Not listed in: Web of Science, DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Quick answers
Is Vacunas indexed in Scopus?
Yes — actively indexed in Scopus, coverage 2005–present, best quartile Q3, CiteScore 3.1.
What quartile is Vacunas in Scopus?
Vacunas is Q3 in Infectious Diseases (rank 191 of 361) and Q3 in Immunology (rank 170 of 243), by CiteScore 2025.
What is the impact factor of Vacunas?
Vacunas is not in the Web of Science Core Collection (SCIE, SSCI, AHCI or ESCI), so Clarivate publishes no Journal Impact Factor for it. Its Scopus CiteScore is 3.1, quartile Q3, 47th percentile. Any "impact factor" quoted elsewhere is not the Clarivate metric. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.250, quartile Q3, with an H-index of 14.
How much does it cost to publish in Vacunas?
The publisher lists an article processing charge of about US$2,960 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Who publishes Vacunas and what is its ISSN?
Vacunas is published by Ediciones Doyma, S.L. Its print ISSN is 1576-9887 and its online ISSN is 1578-8857.
Is Vacunas in Web of Science?
No — it is not currently in the Web of Science core collections (SCIE, SSCI, AHCI or ESCI).
Is Vacunas open access?
No — it is not registered as an open-access journal in DOAJ or Scopus.
How well cited is Vacunas? — open metrics via OpenAlex
Vacunas has an h-index of 19 and a 2-year mean of 0.85 citations per paper (OpenAlex). Its Scopus CiteScore is 3.1, quartile Q3. On 2-year citations it ranks #249 of 354 Scopus journals in Infectious Diseases.
Vacunas published 159 papers in 2025. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
Who publishes in Vacunas? — latest 86 articles, 2024–2026
In its latest 86 research articles (2024–2026), authors are most often from Spain (35.5%), India (15.1%) and Iran (10.9%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Are there integrity warnings for Vacunas? — indicators, not proof of misconduct
Scopus status: Active. 1 retracted paper is recorded (0.8 per 1,000 papers). The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
- Scopus statusActive
- Retracted papers 1 · 0.8 per 1,000 papers
- Problematic Paper Screener flags None flagged
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Official sources & links
Community experience: reader comments on this journal
Related journals
8 journalsIndex data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.